Literature DB >> 25266297

Classifying neurocognitive disorders: the DSM-5 approach.

Perminder S Sachdev1, Deborah Blacker2, Dan G Blazer3, Mary Ganguli4, Dilip V Jeste5, Jane S Paulsen6, Ronald C Petersen7.   

Abstract

Neurocognitive disorders--including delirium, mild cognitive impairment and dementia--are characterized by decline from a previously attained level of cognitive functioning. These disorders have diverse clinical characteristics and aetiologies, with Alzheimer disease, cerebrovascular disease, Lewy body disease, frontotemporal degeneration, traumatic brain injury, infections, and alcohol abuse representing common causes. This diversity is reflected by the variety of approaches to classifying these disorders, with separate groups determining criteria for each disorder on the basis of aetiology. As a result, there is now an array of terms to describe cognitive syndromes, various definitions for the same syndrome, and often multiple criteria to determine a specific aetiology. The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) provides a common framework for the diagnosis of neurocognitive disorders, first by describing the main cognitive syndromes, and then defining criteria to delineate specific aetiological subtypes of mild and major neurocognitive disorders. The DSM-5 approach builds on the expectation that clinicians and research groups will welcome a common language to deal with the neurocognitive disorders. As the use of these criteria becomes more widespread, a common international classification for these disorders could emerge for the first time, thus promoting efficient communication among clinicians and researchers.

Entities:  

Mesh:

Year:  2014        PMID: 25266297     DOI: 10.1038/nrneurol.2014.181

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


  27 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Neurocognitive disorders in DSM-5.

Authors:  Dan Blazer
Journal:  Am J Psychiatry       Date:  2013-06       Impact factor: 18.112

Review 3.  Can the DSM-5 framework enhance the diagnosis of MCI?

Authors:  Mary Ganguli
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

4.  A commentary on the proposed DSM revision regarding the classification of cognitive disorders.

Authors:  Peter V Rabins; Constantine G Lyketsos
Journal:  Am J Geriatr Psychiatry       Date:  2011-03       Impact factor: 4.105

5.  Classification of primary progressive aphasia and its variants.

Authors:  M L Gorno-Tempini; A E Hillis; S Weintraub; A Kertesz; M Mendez; S F Cappa; J M Ogar; J D Rohrer; S Black; B F Boeve; F Manes; N F Dronkers; R Vandenberghe; K Rascovsky; K Patterson; B L Miller; D S Knopman; J R Hodges; M M Mesulam; M Grossman
Journal:  Neurology       Date:  2011-02-16       Impact factor: 9.910

Review 6.  "What's in a name?" Delirium by any other name would be as deadly. A review of the nature of delirium consultations.

Authors:  Aditya Joshi; Venkatesh Basappa Krishnamurthy; Heather Purichia; Laura Hollar-Wilt; Edward Bixler; Mark Rapp
Journal:  J Psychiatr Pract       Date:  2012-11       Impact factor: 1.325

Review 7.  Frontotemporal dementia and related disorders: deciphering the enigma.

Authors:  Keith A Josephs
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

8.  Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.

Authors:  G C Román; T K Tatemichi; T Erkinjuntti; J L Cummings; J C Masdeu; J H Garcia; L Amaducci; J M Orgogozo; A Brun; A Hofman
Journal:  Neurology       Date:  1993-02       Impact factor: 9.910

9.  Neurocognitive disorders: cluster 1 of the proposed meta-structure for DSM-V and ICD-11.

Authors:  P Sachdev; G Andrews; M J Hobbs; M Sunderland; T M Anderson
Journal:  Psychol Med       Date:  2009-10-01       Impact factor: 7.723

Review 10.  Clinical diagnostic criteria for dementia associated with Parkinson's disease.

Authors:  Murat Emre; Dag Aarsland; Richard Brown; David J Burn; Charles Duyckaerts; Yoshikino Mizuno; Gerald Anthony Broe; Jeffrey Cummings; Dennis W Dickson; Serge Gauthier; Jennifer Goldman; Christopher Goetz; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Ian McKeith; Warren Olanow; Werner Poewe; Niall Quinn; Christina Sampaio; Eduardo Tolosa; Bruno Dubois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

View more
  149 in total

1.  Regression: Diagnosis, Evaluation, and Management.

Authors:  Hermioni N Lokko; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2015-05-14

Review 2.  The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review.

Authors:  Mary Hannan; Alana Steffen; Lauretta Quinn; Eileen G Collins; Shane A Phillips; Ulf G Bronas
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

3.  Standardized Operational Protocol for Human Brain Banking in China.

Authors:  Wenying Qiu; Hanlin Zhang; Aimin Bao; Keqing Zhu; Yue Huang; Xiaoxin Yan; Jing Zhang; Chunjiu Zhong; Yong Shen; Jiangning Zhou; Xiaoying Zheng; Liwei Zhang; Yousheng Shu; Beisha Tang; Zhenxin Zhang; Gang Wang; Ren Zhou; Bing Sun; Changlin Gong; Shumin Duan; Chao Ma
Journal:  Neurosci Bull       Date:  2018-11-08       Impact factor: 5.203

Review 4.  Meta-analytic evidence for a core problem solving network across multiple representational domains.

Authors:  Jessica E Bartley; Emily R Boeving; Michael C Riedel; Katherine L Bottenhorn; Taylor Salo; Simon B Eickhoff; Eric Brewe; Matthew T Sutherland; Angela R Laird
Journal:  Neurosci Biobehav Rev       Date:  2018-06-23       Impact factor: 8.989

5.  Systematic review and meta-analysis investigating moderators of long-term effects of exercise on cognition in healthy individuals.

Authors:  Sebastian Ludyga; Markus Gerber; Uwe Pühse; Vera N Looser; Keita Kamijo
Journal:  Nat Hum Behav       Date:  2020-03-30

6.  Population Neuroscience: Dementia Epidemiology Serving Precision Medicine and Population Health.

Authors:  Mary Ganguli; Emiliano Albanese; Sudha Seshadri; David A Bennett; Constantine Lyketsos; Walter A Kukull; Ingmar Skoog; Hugh C Hendrie
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Jan-Mar       Impact factor: 2.703

7.  Cognitive Impairment in Non-Dialysis-Dependent CKD and the Transition to Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Meera N Harhay; Dawei Xie; Xiaoming Zhang; Chi-Yuan Hsu; Eric Vittinghoff; Alan S Go; Stephen M Sozio; Jacob Blumenthal; Stephen Seliger; Jing Chen; Rajat Deo; Mirela Dobre; Sanjeev Akkina; Peter P Reese; James P Lash; Kristine Yaffe; Manjula Kurella Tamura
Journal:  Am J Kidney Dis       Date:  2018-05-02       Impact factor: 8.860

8.  Mild Neurocognitive Disorder: A Model for Accelerated Biological Aging?

Authors:  Dilip V Jeste; Barton W Palmer
Journal:  Am J Geriatr Psychiatry       Date:  2016-08-25       Impact factor: 4.105

Review 9.  Lewy body dementias.

Authors:  Zuzana Walker; Katherine L Possin; Bradley F Boeve; Dag Aarsland
Journal:  Lancet       Date:  2015-10-24       Impact factor: 79.321

10.  Beta-alanine supplementation in patients with COPD receiving non-linear periodised exercise training or neuromuscular electrical stimulation: protocol of two randomised, double-blind, placebo-controlled trials.

Authors:  Roy Meys; Anouk A F Stoffels; Jana de Brandt; Hieronymus W H van Hees; Frits M E Franssen; Maurice J H Sillen; Emiel F M Wouters; Chris Burtin; Peter Klijn; Eline Bij de Vaate; Bram van den Borst; Jacqueline M Otker; Jos Donkers; Florence N Schleich; Maurice Hayot; Pascal Pomiès; Inge Everaert; Wim Derave; Martijn A Spruit
Journal:  BMJ Open       Date:  2020-09-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.